Trials / Completed
CompletedNCT03395262
An Examination of a Weight Loss Formula on Health
An Examination of a Novel Weight Loss Formula on Anthropometry and Indices of Cardiovascular Disease Risk
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Texas A&M University · Academic / Other
- Sex
- All
- Age
- 30 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.
Detailed description
Obesity remains a problem for overall health and risk for cardiovascular disease worldwide. While dietary modification and increased levels of physical activity remain steadfast recommendations, alternative strategies related to supplementation remain an interest for the general populace and medical communities. A potential objection to the use of dietary supplements is that they often contain stimulants designed to increase metabolism. However, consumers and health practitioners alike are wary of such formulae; hence, the continued investigation of non-stimulant supplements is warranted. Therefore the aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Active with caffeine | Novel formula with caffeine |
| DIETARY_SUPPLEMENT | Active without caffeine | Novel formula without caffeine |
| DIETARY_SUPPLEMENT | Placebo | Dextrose placebo |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2018-03-31
- Completion
- 2018-12-31
- First posted
- 2018-01-10
- Last updated
- 2019-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03395262. Inclusion in this directory is not an endorsement.